Weiss Multi-Strategy Advisers’s Trillium Therapeutics Inc. TRIL Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-499,069	Closed	-$8.76M	–	841
2021 Q3	$8.76M	Buy	+499,069	New	+$5.83M	0.19%	171
2015 Q3	–	Sell	-20,000	Closed	-$436K	–	520
2015 Q2	$436K	Buy	+20,000	New	+$456K	0.02%	390

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

Weiss Multi-Strategy Advisers's TRIL Position: Q4 2021 in Review

Weiss Multi-Strategy Advisers sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 499,069 shares — an estimated $8.76M sold.

Weiss Multi-Strategy Advisers first reported a position in TRIL in Q2 2015 and held it in 2 quarters. The position peaked at $8.76M in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

Weiss Multi-Strategy Advisers reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 499,069 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $8.76M.
Weiss Multi-Strategy Advisers first reported a position in Trillium Therapeutics Inc. in Q2 2015 and held it in 2 quarters.
Weiss Multi-Strategy Advisers's Trillium Therapeutics Inc. position peaked at $8.76M in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2021, filed 14 Feb 2022.